Sign in

CIK 0002022626

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Upstream Bio, Inc.

Sign in to watch
Ticker
UPB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-208-2466
Business address
890 WINTER STREET, SUITE 200, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$27,604
in 5 filings

Net −$27,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-16 Deykin Aaron Chief Medical Officer Sale −895 $5.49 $5K 32,302
2026-06-16 Deykin Aaron Chief Medical Officer Sale −895 $6.10 $5K 33,197
2026-03-16 Deykin Aaron Chief Medical Officer Sale −894 $9.29 $8K 32,687
2026-01-02 Deykin Aaron Chief Medical Officer Grant or award +32,000 33,581
2026-01-02 Deykin Aaron Chief Medical Officer Grant or award · Stock Option (Right to Buy) +96,000 96,000
2025-02-06 Deykin Aaron Chief Medical Officer Grant or award · Stock Option (Right to Buy) +165,000 165,000

Page 1 of 1 · 6 trades